Thrombophilic Mutations in Iran

S. Zeinali; F. Duca; B. Zarbakhsh; L. Tagliabue; P.M. Mannucci

doi:10.1055/s-0037-1613816

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2000; 83(02): 351-352
DOI: 10.1055/s-0037-1613816

Letters to the Editor

Schattauer GmbH

Thrombophilic Mutations in Iran

S. Zeinali

¹From the Dept of Biotechnology, Pasteur Institute of Iran, Pasteur St., Tehran, Iran – zeinali@institute.pasteur.ac.ir

²Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, IRCCS Maggiore Hospital of Milano, Milano, Italy

,

F. Duca

²Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, IRCCS Maggiore Hospital of Milano, Milano, Italy

,

B. Zarbakhsh

¹From the Dept of Biotechnology, Pasteur Institute of Iran, Pasteur St., Tehran, Iran – zeinali@institute.pasteur.ac.ir

,

L. Tagliabue

²Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, IRCCS Maggiore Hospital of Milano, Milano, Italy

,

P.M. Mannucci

²Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, IRCCS Maggiore Hospital of Milano, Milano, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
2 Pepe G, Riccards O, Camacho V, Brunelli T, Gori AN, Giusti B, Attanasio M, Prisco D, Gensini GF, Abbate R. Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost 1997; 77: 329-31.
3 Gou D, Naipal A, Reitsma PH. World distribution of factor V Leiden mutation. Lancet 1996; 347: 59.
4 Dzimiri N, Meyer B. World distribution of factor V Leiden. Lancet 1996; 347: 481-2.
5 Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women, implication for venous thromboembolism screening. JAMA 1997; 277: 1305-7.
6 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
7 Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-8.
8 Souto JC, Coll I, Liobet D, del Rio E, Oliver A, Mateo J, Borrell M, Fontcuberta J. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998; 80: 366-9.
9 Franco RF, Santos SE, Elion J, Tavella MH, Zago MA. Prevalence of the G20210A polymorphism in the 3’-untranslated region of the prothrombin gene in different human populations. Acta Haematol 1998; 100: 9-12.
10 Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. NEJM 1998; 338: 1793-7.
11 Gul A, Ozbek U, Ozturk C, Inanc M, Konice M, Ozcelik T. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet’s Disease. Br J Rheum 1996; 35: 1178-80.
12 Gurgey A, Rustemov R, Parlak H, Balta G. Prevalence of factor V Leiden and methylenetetrahydrofolate reductase C677T mutation in Azarbaijan. Thromb Haemost 1998; 80: 520-1.
13 Akar N, Akar E, Dalgin G, Sozuoz A, Omurlu K, Cin S. Frequency of factor V (1691 G-A) mutation in Turkish population. Thromb Haemost 1997; 78: 1527-9.